共 28 条
- [10] A phase II trial of subcutaneous recombinant human interleukin 11 (rhIL-11) with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997. [J]. BLOOD, 2000, 96 (11) : 323A - 323A